1.

The Committee for Proprietary Medicinal Products and the Committee for Veterinary Medicinal Products shall each consist of two members nominated by each Member State for a term of three years which shall be renewable. They shall be chosen by reason of their role and experience in the evaluation of medicinal products for human and veterinary use as appropriate and shall represent their competent authorities. The Executive Director of the Agency or his representative and representatives of the Commission shall be entitled to attend all meetings of the Committees, their working parties and expert groups. Members of each Committee may arrange to be accompanied by experts.

← Article 52 · All articles · 2. →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.